Edgardo Alania/Secardiologia.es
Sep 4, 2026, 02:18
Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
Edgardo Alania, Cardiologist at Hospital Marina Salud (Denia), shared a post on X:
“ENRICH-AF (n is equal to 948): Edoxaban after intracranial haemorrhage did not reduce stroke or systemic embolism (11.8% vs 12.8%; HR 0.88) but increased major bleeding (11.6% vs 5.2%; HR 2.23).
Routine edoxaban is not supported in this unselected population.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB